Ladenburg Thalmann Healthcare Conference July 13, 2021 Forward-looking Statements 2 This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the design, initiation, timing and submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for tebipenem HBr and the potential approval of tebipenem HBr by the FDA; future commercialization, the potential number of patients who could be treat ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Ashley Robinson - Investor Relations Ankit Mahadevia - Chief Executive Officer David Melnick - Chief Medical Officer Cristina Larkin - Chief Operating Officer Sath Shukla - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen Louise Chen - Cantor Fitzgerald Kevin DeGeeter - Oppenheimer Esther Hong - Berenberg Ram Selvaraju - H.C. Wainwright Operator Greetings and welcome to ...

Corporate Presentation Oppenheimer Healthcare Conference March 16, 2021 Forward-looking Statements 2 This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the design, initiation, timing and submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for tebipenem HBr and the potential approval of tebipenem HBr by the FDA; future commercialization, the potential number of patients w ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Sharon Klahre – Vice President of Investor Relations and Strategic Finance Ankit Mahadevia – Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Sath Shukla – Chief Financial Officer Conference Call Participants Lyla Youssef – Cowen & Company Louise Chen – Cantor Fitzgerald Kevin DeGeeter – Oppenheimer Esther Hong – Berenberg Ram Selvaraju ...

Corporate Presentation Evercore ISI HealthCONx Conference December 3, 2020 Forward-looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the design, initiation, timing and submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for tebipenem HBr and the potential approval of tebipenem HBr by the FDA; future commercialization, the potential number of patients ...

PE Corporate Presentation Stifel Healthcare Conference November 18, 2020 Forward-looking Statements 2 This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the initiation, timing and submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for tebipenem HBr and the potential approval of tebipenem HBr by the FDA; future commercialization, the potential number of patients who coul ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Sharon Klahre – Vice President of Investor Relations and Strategic Finance Ankit Mahadevia – Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Steve DiPalma – Interim Chief Financial Officer Conference Call Participants Carvey Leung – Cantor Vishal Sethi – Cowen Ellen Sands – Stifel Operator Operator Good day, and welcome to the Spero ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Sharon Klahre – Senior Director-Investor Relations Ankit Mahadevia – Co-Founder, President and Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Steve DiPalma – Interim Chief Financial Officer Conference Call Participants Ritu Baral – Cowen Louise Chen – Cantor Stephen Willey – Stifel Ram Selvaraju – H.C. Wainwright Chi Fong – Bank of Am ...

Corporate Presentation Bank of America Healthcare Conference May 13, 2020 Forward-looking Statements 2 This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the initiation, timing, progress and results of the Company's preclinical studies and clinical trials and its research and development programs, including management's assessment of such results; regulatory activities, including the Company's expectation th ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2020 Results Conference Call May 8, 2020 10:00 AM ET Company Participants Sharon Klahre - VP of IR and Strategy Dr. Ankit Mahadevia - Chief Executive Officer Dr. David Melnick - Chief Medical Officer Cristina Larkin - Chief Operating Officer Steve DiPalma - Interim Chief Financial Officer Conference Call Participants Louise Chen - Cantor Stephen Willey - Stifel Kevin DeGeeter - Oppenheimer Esther Hong - Janney Ram Selvaraju - H.C. Wainwright Chi Fong - Bank of Ameri ...